OBIO compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name

OBIOOrchestra BioMed Holdings, Inc.

Mkt capRevenueRevenue

SYKStryker Corp

Mkt capRevenueRevenue

Compare

OBIOOrchestra BioMed Holdings, Inc.

SYKStryker Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OBIO

No earnings history for OBIO.

SYK

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.2%▼−6.38%×0.89

Q2 FY26±6.5%▼−6.42%×0.98

Q1 FY26±5.8%▼−6.47%×1.12

Jan 30 '26±5.2%▲+4.31%×0.83

= impliedOBIO realized, solidSYK realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

OBIOOrchestra BioMed Holdings, Inc.

5.67▼−0.17%· post 5.92

Mkt cap$342.6MRevenue$88,000Q2 FY26Revenue$33MFY25

SYKStryker Corp

326.90▲+0.32%· post 326.90

ClosedNov 9 '26

Mkt cap$124.1BRevenue$6.5BQ3 FY26Revenue$25.1BFY25

Compare

ClosedNov 9 '26

OBIOOrchestra BioMed Holdings, Inc.

SYKStryker Corp

5.67▼−0.17%post 5.92

Price

326.90▲+0.32%post 326.90

$342.6M

Mkt cap

$124.1B

Q2 FY26$88,000

Revenue

$6.5BQ3 FY26

FY25$33M

Revenue

$25.1BFY25

OBIO5.67▼−0.17%vsSYK326.90▲+0.32%ClosedNov 9 '26